Novel DALTAC Approach Targets Prostate Cancer Proteins in Preclinical Models
Researchers developed domain-alteration chimeras that bind two cooperating proteins to suppress prostate cancer tumors in preclinical models while sparing normal ...
Researchers developed domain-alteration chimeras that bind two cooperating proteins to suppress prostate cancer tumors in preclinical models while sparing normal ...
Preclinical experiments demonstrate that novel domain-alteration chimeras rewire oncogenic protein complexes, inhibiting prostate cancer growth while sparing healthy tissue.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.